• 1
    National Institutes of Health (1998) Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: the evidence report. Obes Res. 6: (Suppl 2), 51S209S.
  • 2
    Sowers, J.R. (2003) Obesity as a cardiovascular risk factor. Am J Med. 8: (Suppl 8A), 37S41S.
  • 3
    Kaplan, NM. (1989) The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med. 149: 15141520.
  • 4
    Han, S., Williams, K., Sattar, N., et al (2002) Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study. Obes Res. 10: 923931.
  • 5
    Rimm, B., Stampfer, M. J., Giovannucci, E., et al (1995) Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol. 141: 11171127.
  • 6
    Havlik, R. J., Hubert, H. B., Fabsitz, R. R., et al (1983) Weight and hypertension. Ann Intern Med. 98: 855859.
  • 7
    Grundy, SM. (2002) Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 105: 26962698.
  • 8
    Despres, J. (1994) Dyslipidemia and obesity. Clin Endocrinol Metab. 8: 629660.
  • 9
    Eckel, R. H., Krauss, RM. (1998) American Heart Association call to action: obesity as a major risk factor for coronary heart disease. Circulation 97: 20992100.
  • 10
    National Cholesterol Education Program (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Circulation 106: 31433421.
  • 11
    Andres, R. (1980) Effect of obesity on total mortality. Int J Obes Relat Metab Disord. 4: 381386.
  • 12
    Sims, A. (2001) Are there persons who are obese, but metabolically healthy? Metabolism 50: 14991504.
  • 13
    Brochu, M., Tchernof, A., Dionne, I. J., et al (2001) What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab. 86: 10201025.
  • 14
    Karelis, A. D., St-Pierre, D. H., Conus, F., Rabasa-Lhoret, R., Poehlman, ET. (2004) Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab. 89: 25692575.
  • 15
    Marchesini, G., Melchionda, N., Apolone, G., et al (2004) QUOVADIS Study Group: the metabolic syndrome in treatment-seeking obese persons. Metabolism 53: 435440.
  • 16
    Iacobellis, G., Ribaudo, M. C., Leto, G., et al (2002) Influence of excess fat on cardiac morphology and function: study in uncomplicated obesity. Obes Res. 10: 767773.
  • 17
    Iacobellis, G. (2004) True uncomplicated obesity is not related to increased left ventricular mass and systolic dysfunction. J Am Coll Cardiol. 44: 2257
  • 18
    Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., Turner, RC. (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412419.
  • 19
    Matsuda, M., DeFronzo, RA. (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 14621470.
  • 20
    Grundy, S. M., Cleeman, J. I., Merz, C. N., et al (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 13: 227239. (110),.
  • 21
    NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease (1993) NIH Consensus Conference: triglyceride, high-density lipoprotein, and coronary heart disease. JAMA 269: 505510.
  • 22
    Stampfer, M. J., Sacks, F. M., Salvini, S., Willett, W. C., Hennekens, CH. (1991) A prospective study of cholesterol apolipoproteins and the risk of myocardial infarction. N Engl J Med. 325: 373381.
  • 23
    McLaughlin, T., Allison, G., Abbasi, F., Lamendola, C., Reaven, G. (2004) Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. Metabolism 53: 495499.
  • 24
    Fang, J., Alderman, NH. (2000) Serum uric acid and cardiovascular mortality; the NHANES I epidemiologic follow-up study. JAMA 283: 24042410.
  • 25
    Cannon, C. P., McCabe, C. H., Wilcox, R. G., et al (2001) Association of white blood cell count with increased mortality in acute myo-cardial infarction and unstable angina pectoris. Am J Cardiol. 87: 636639.
  • 26
    Biasucci, L. M., Liuzzo, G., Grillo, R. L., et al (1999) Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 99: 855860.
  • 27
    World Health Organization (1998) Obesity: Prevention and Managing the Global Epidemic. Report of a WHO Consultation on Obesity World Health Organization Geneva, Switzerland.
  • 28
    Friedewald, W., Levy, R., Fredrickson, D. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18: 499502.
  • 29
    American Diabetes Association (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20: 11831197.
  • 30
    U.S. Department of Health and Human Services, National Heart, Lung, and Blood Institute (2003) The 7th Report on Joint International Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure Department of Health and Human Services, National Heart, Lung, and Blood Institute. Bethesda, MD: U.S.
  • 31
    Alpert, J. S., Thygesen, K., Antman, E., Bassand, JP. (2000) Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 36: 959969.
  • 32
    Alfakih, K., Walters, K., Jones, T., Ridgway, J., Hall, A. S., Sivananthan, M. (2004) New gender-specific partition values for ECG criteria of left ventricular hypertrophy: recalibration against cardiac MRI. Hypertension 44: 175179.
  • 33
    Janssen, I., Katzmarzyk, P. T., Ross, R. (2004) Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 79: 379384.
  • 34
    Rexrode, M., Buring, J. E., Manson, JE. (2001) Abdominal and total adiposity and risk of coronary heart disease in men. Int J Obes Relat Metab Disord. 25: 10471056.
  • 35
    Reaven, GM. (1988) Role of insulin resistance in human disease. Diabetes 37: 15951607.
  • 36
    DeFronzo, R. A., Ferrannini, E. (1991) Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173194.
  • 37
    Iacobellis, G., Ribaudo, M. C., Zappaterreno, A., et al (2003) Relationship of insulin sensitivity and left ventricular mass in uncomplicated obesity. Obes Res. 11: 518524.
  • 38
    Isomaa, B., Almgren, P., Tuomi, T., et al (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24: 683689.
  • 39
    Ferrannini, E., Natali, A., Bell, P., Cavallo-Perin, P., Lalic, N., Mingrone, G. (1997) Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest. 100: 11661173.
  • 40
    Kip, K. E., Marroquin, O. C., Kelley, D. E., et al (2004) Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation 109: 706713.